The Australian share market closed the week with the S&P/ASX 200 down 0.62%, marking a second consecutive weekly decline. While the broader benchmark slipped, small caps managed a 0.90% weekly gain, underscoring a rotation rather than a broad sell-off. The All Ordinaries fell 0.31% on Friday to 9,269.7, while the ASX 200 settled at 9,058.9, down 0.27% on the day.
Leadership was narrow and earnings-driven. Healthcare was the standout performer, surging 9.5% for the week, propelled by CSL's better-than-expected full-year results. Materials followed with a 5.3% gain, supported by firmer commodity prices, and energy added 4.0% as Brent crude hovered near US$93 per barrel. On the flip side, discretionary stocks tumbled 6.8%, financials fell 4.9%, and real estate dropped 4.5%, reflecting renewed concerns about interest rates and stretched valuations.
The technology sector also struggled, losing 3.6% for the week. This divergence highlights a market that is increasingly selective, with investors favoring defensive and resource-linked names while shunning rate-sensitive and high-multiple sectors.
Earnings Highlights
CSL (ASX:CSL) reported underlying net profit after tax of US$3.10 billion for fiscal 2026, with earnings per share of 643 cents, both slightly above consensus. However, the dividend of 292 cents fell short of the 298.1-cent estimate, tempering enthusiasm. Despite this, the stock rose on the results, contributing to the healthcare sector's strong weekly performance.
Guzman y Gomez (ASX:GYG) jumped 11.3% on Friday after posting 29.7% annual profit growth, a standout on an otherwise weak day for consumer names. Equity Trustees (ASX:EQT) gained 9.3% following a takeover offer. In contrast, Inghams (ASX:ING) dropped 7.2% on bird-flu warnings and higher transport costs. Commonwealth Bank (ASX:CBA) slid 5.15% for the week as investors rotated away from expensive financials.
Macro and Cross-Asset Context
The Australian dollar firmed to 0.7140 against the US dollar, up 0.38% in late trading. Higher oil prices supported energy shares but also stoked inflation fears, adding pressure on long-duration assets such as property and retail. The market is now bracing for the July consumer price index (CPI) release on Wednesday, with consensus pointing to headline inflation of 3.5% year-on-year and trimmed mean around 3.6%.
A softer CPI print could ease duration pressure and broaden the rally, potentially lifting rate-sensitive sectors. Conversely, sticky inflation or another leg higher in oil would keep yields elevated and valuation compression in control.
Week Ahead: Key Catalysts
The coming week is packed with corporate results and economic data. Monday sees the ASX reopen, with results from Aldoro Resources (ALD), Bendigo and Adelaide Bank (BEN), Endeavour Group (EDV), Pilbara Minerals (PLS), Reece (REH), and Vintage Energy (VNT). Tuesday brings Coles (COL), Scentre Group (SCG), and Woodside Energy (WDS), along with an RBA speech.
Wednesday's CPI is the marquee event, followed by results from Domino's Pizza (DMP), Flight Centre (FLT), Lynas Rare Earths (LYC), Woolworths (WOW), and Wisetech Global (WTC). Thursday features private capital expenditure data and results from Mineral Resources (MIN), Qantas (QAN), Ramsay Health Care (RHC), South32 (S32), and Wesfarmers (WES), plus the RBA Bulletin.
Investors will also watch for any shifts in the RBA's policy stance, with the domestic-markets speech on Tuesday providing potential clues. The market's immediate focus, however, is on whether inflation continues to moderate, which could determine the trajectory for interest rates and equity valuations in the months ahead.
Overall, the rotation from growth to value and the resilience of healthcare and materials suggest a cautious but not bearish tone. The upcoming data and earnings will be critical in shaping the next phase of the market's direction.
